Oncolytics Biotech Inc. (ONCY)

NASDAQ: ONCY · Real-Time Price · USD

1.040

+0.105 (11.23%)

At close: May 29, 2026, 4:00 PM EDT

1.070

+0.030 (2.88%)

After-hours: May 29, 2026, 6:35 PM EDT

Oncolytics Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7.64	5.2	11.08	34.91	11.67	41.26
Short-Term Investments	-	-	-	-	20.47	-
Cash & Short-Term Investments	7.64	5.2	11.08	34.91	32.14	41.26
Cash Growth	-50.09%	-53.05%	-68.27%	8.63%	-22.11%	32.17%
Other Receivables	1.34	0.57	0.05	0.02	0.52	0.87
Total Trade Receivables	1.34	0.57	0.05	0.02	0.52	0.87
Other Current Assets	1.44	1.07	1.31	3.25	3.03	2.78
Total Current Assets	10.41	6.84	12.44	38.17	35.68	44.9
Net Property, Plant & Equipment	0.94	0.74	0.99	0.65	0.65	0.98
Other Long-Term Assets	-	-	-	-	1	-
Total Assets	11.35	7.58	13.42	38.82	37.33	45.88
Accounts Payable	3.73	3.5	0.76	3.57	3.65	1.99
Accrued Expenses	3.58	2.33	2.57	-	-	-
Current Portion of Leases	0.23	0.19	0.2	0.13	0.22	0.29
Other Current Liabilities	-	0.08	1.36	0.53	0.08	0.41
Total Current Liabilities	7.54	6.1	4.89	4.24	3.95	2.69
Long-Term Leases	0.48	0.37	0.56	0.29	0.16	0.36
Other Long-Term Liabilities	10.46	4.91	4.68	6.73	6.73	6.73
Total Long-Term Liabilities	10.94	5.28	5.24	7.02	6.89	7.09
Total Liabilities	18.48	11.38	10.12	11.26	10.83	9.78
Common Stock	-	-	-	430.91	404.04	391.35
Additional Paid-in Capital	594.19	419.47	397.67	42.12	40.05	37.78
Accumulated Other Comprehensive Income	8.65	6.23	6.36	0.54	0.66	0.39
Retained Earnings	-609.98	-429.5	-400.74	-446	-418.25	-393.42
Shareholders' Equity	-7.13	-3.8	3.3	27.56	26.5	36.1
Total Liabilities & Equity	11.35	7.58	13.42	38.82	37.33	45.88
Total Debt	0.71	0.56	0.76	0.42	0.37	0.66
Net Cash (Debt)	6.93	4.64	10.32	34.49	31.77	40.61
Net Cash Growth	49.40%	-55.04%	-70.08%	8.58%	-21.77%	31.77%
Net Cash Per Share	0.07	0.05	0.14	0.51	0.55	0.76
Book Value	-7.13	-3.8	3.3	27.56	26.5	36.1
Book Value Per Share	-0.07	-0.04	0.04	0.41	0.46	0.67
Tangible Book Value	-7.13	-3.8	3.3	27.56	26.5	36.1
Tangible Book Value Per Share	-0.07	-0.04	0.04	0.41	0.46	0.67

Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q